Blueberries Medical Corp.
BBRRF
$0.01
$0.00-5.51%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -20.26% | -38.10% | -42.06% | 1.70% | -41.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.26% | -38.10% | -42.06% | 1.70% | -41.58% |
| Cost of Revenue | -47.44% | -52.32% | -14.13% | -24.76% | -53.20% |
| Gross Profit | 21.85% | -5.71% | -49.58% | 82.18% | -5.03% |
| SG&A Expenses | -75.31% | 13.73% | -20.31% | -17.08% | 186.57% |
| Depreciation & Amortization | -94.48% | -11.86% | -9.74% | -2.23% | -9.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -74.77% | -14.80% | -19.02% | -16.88% | 124.11% |
| Operating Income | 78.72% | -18.45% | 12.76% | 21.18% | -181.94% |
| Income Before Tax | 77.62% | -29.54% | -6.43% | 39.13% | -182.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 77.62% | -29.54% | -6.43% | 39.13% | -182.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.62% | -29.54% | -6.43% | 39.13% | -182.80% |
| EBIT | 78.72% | -18.45% | 12.76% | 21.18% | -181.94% |
| EBITDA | 78.16% | -23.65% | 13.22% | 23.27% | -204.62% |
| EPS Basic | 84.62% | 0.00% | 0.00% | 50.00% | -160.00% |
| Normalized Basic EPS | 75.00% | 0.00% | 0.00% | 50.00% | -166.67% |
| EPS Diluted | 84.62% | 0.00% | 0.00% | 50.00% | -160.00% |
| Normalized Diluted EPS | 75.00% | 0.00% | 0.00% | 50.00% | -166.67% |
| Average Basic Shares Outstanding | 22.11% | 35.43% | 24.07% | 24.07% | 1.60% |
| Average Diluted Shares Outstanding | 22.11% | 35.43% | 24.07% | 24.07% | 1.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |